KATIE STAPHOS: Open Payments
NPI 1760488001 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 32 payments from 14 companies in 2025. Trend: 2023 $1,716 · 2024 $1,459 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 1 | $149 |
| Novartis Pharmaceuticals Corporation | 8 | $136 |
| Shockwave Medical, Inc | 3 | $91 |
| Amgen Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Merck Sharp & Dohme LLC | 4 | $65 |
| Boston Scientific Corporation | 1 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
Products named: LEQVIO, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, REPATHA, FARXIGA, VERQUVO, ELIQUIS, WATCHMAN FLX, AMVUTTRA.
Industry payments across NY — which companies pay providers there.
